Research prototype, not medical advice.

05 — Disabled macroautophagy

Primary hallmark ("damage"), added as a hallmark in its own right in López-Otín et al., Cell 2023 (doi:10.1016/j.cell.2022.11.001); in 2013 it was included in loss of proteostasis (file 04).

1. Definition

Age-related decline of macroautophagy: the process by which the cell encloses portions of its contents (aggregated proteins, worn-out organelles such as mitochondria, lipid droplets, microbes) in a double-membrane vesicle (the autophagosome) and then delivers them to the lysosome to be digested and recycled. Its activity falls with age in most tissues; blocking it genetically accelerates degeneration and activating it extends life in several animal species (Aman 2021, doi:10.1038/s43587-021-00098-4; Rubinsztein 2011, doi:10.1016/j.cell.2011.07.030).

In plain terms: autophagy ("self-eating") is the cell's sorting and recycling service. It packs waste and worn-out parts into a bag and takes them to the recycling plant (the lysosome), which cuts them into reusable materials. With age, the trucks come less often and the plant runs slowly: waste builds up.

2. Mechanisms and sources

Normal operation

What degrades with age (Hansen 2018, doi:10.1038/s41580-018-0033-y)

Causal evidence in animals

3. Symptoms and clinical manifestations

Human genetics: mutations in autophagy genes cause or promote diseases (review: Levine & Kroemer 2019, doi:10.1016/j.cell.2018.09.048):

Associated age-related diseases: neurodegeneration (Alzheimer's, Parkinson's, Huntington's), sarcopenia (muscle wasting), heart failure, hepatic steatosis (fatty liver), type 2 diabetes, infections, some cancers (ambivalent role: autophagy slows the appearance of tumours but helps established tumours survive).

Mitophagy and the brain: in mouse models of Alzheimer's, stimulating mitophagy reduces amyloid-β and tau and restores memory (Fang 2019, doi:10.1038/s41593-018-0332-9).

4. Interactions with the other hallmarks

Hallmark (2023 numbering)Link with disabled macroautophagy
1. Genomic instabilityAutophagy clears micronuclei and mitochondria that produce free radicals; its decline increases DNA damage.
2. Telomere attritionIndirect link (senescence, oxidative stress).
3. Epigenetic alterationsExpression of ATG genes and TFEB is epigenetically regulated; spermidine induces autophagy by inhibiting the acetyltransferase EP300 (Pietrocola 2015, doi:10.1038/cdd.2014.215).
4. Loss of proteostasisThe two hallmarks overlap: macroautophagy is the only route able to clear large aggregates (file 04).
6. Deregulated nutrient sensingmTORC1 (brake) and AMPK (accelerator) are the main switches; most longevity interventions (caloric restriction, rapamycin) work through autophagy (Madeo 2015).
7. Mitochondrial dysfunctionMitophagy clears defective mitochondria; its decline lets them accumulate.
8. Cellular senescenceAmbivalent role: autophagy prevents senescence but also contributes to producing the senescent secretome.
9. Stem cell exhaustionIn mice, old muscle stem cells lose their autophagy, which tips them into senescence (García-Prat 2016, doi:10.1038/nature16187); blood stem cells need autophagy to stay quiescent and functional (Ho 2017, doi:10.1038/nature21388).
10. Altered intercellular communicationAutophagy-dependent unconventional secretion of proteins and vesicles.
11. Chronic inflammationAutophagy restrains the NLRP3 inflammasome; its decline promotes "inflammaging".
12. DysbiosisXenophagy: defence against gut bacteria (Crohn's/ATG16L1 link). The microbiota produces autophagy inducers (urolithin A, spermidine).

5. Existing or investigational remedies

InterventionTargetLevel of evidenceKey resultSource
RapamycinInhibits mTORC1 → activates autophagySolid preclinical; human phase 2 trialsExtends mouse lifespan even when started late (Harrison 2009); an analogue (everolimus) improves the vaccine response of older people (Mannick 2014); TORC1 inhibition reduces infections (Mannick 2018). PEARL trial (1 year, low doses): well tolerated, modest effects on some markers (Moel 2025).doi:10.1038/nature08221; doi:10.1126/scitranslmed.3009892; doi:10.1126/scitranslmed.aaq1564; doi:10.18632/aging.206235; review Mannick 2021 doi:10.1016/S2666-7568(21)00062-3
SpermidineNatural autophagy inducerPreclinical; human observational; human randomised trialExtends the life of yeast, worm and fly (Eisenberg 2009) and protects the mouse heart (Eisenberg 2016). High dietary intake associated with lower mortality (Bruneck cohort, Kiechl 2018). SmartAge trial (12 months, 100 older adults): no effect on memory (Schwarz 2022).doi:10.1038/ncb1975; doi:10.1038/nm.4222; doi:10.1093/ajcn/nqy102; doi:10.1001/jamanetworkopen.2022.13875
Urolithin A (microbial metabolite of pomegranate ellagitannins)MitophagyPreclinical; human phase 1-2 trialsExtends worm life, improves mouse muscle (Ryu 2016); safe, with a mitochondrial signature in humans (Andreux 2019); 4-month trial in 66 older adults: no improvement in the primary endpoint (walking distance), gains in muscle endurance (Liu 2022).doi:10.1038/nm.4132; doi:10.1038/s42255-019-0073-4; doi:10.1001/jamanetworkopen.2021.44279
Intermittent fasting / caloric restrictionmTOR ↓, AMPK ↑Solid preclinical; human trials (metabolic markers)Cardiometabolic benefits in humans; autophagy induction hard to measure directlyde Cabo & Mattson 2019, doi:10.1056/NEJMra1905136
Physical exerciseMuscle autophagy (via BCL2-Beclin 1)Preclinical (mechanism); established clinical benefitsIn mice, exercise-induced autophagy is required for some metabolic benefitsHe 2012, doi:10.1038/nature10758
Genetic activation (Atg5, Beclin 1 F121A, Rubicon deletion)Autophagy machineryPreclinicalLifespan extension in the mouse or the wormPyo 2013; Fernández 2018; Nakamura 2019
Stimulating mitophagy (NAD+, urolithin A)MitochondriaPreclinical (Alzheimer's models)Reduces amyloid and tau, improves memoryFang 2019

Finding: rapamycin is the strongest candidate in animals; in humans, the data concern markers (immunity, infections) in small samples. Supplements (spermidine, urolithin A) have modest or negative human results on their primary endpoints. There is no reliable measure of autophagy in a living person.

6. Open questions

  1. Measurement: how to quantify autophagic flux in humans (blood, biopsy)? Without a biomarker, an intervention cannot be dosed.
  2. Specificity: can selective autophagy (mitophagy in muscle, aggrephagy in neurons) be activated rather than a global effect?
  3. Cancer: activating autophagy can help an existing tumour survive; which patient profile?
  4. Rapamycin in humans: what dose and schedule (intermittent) target mTORC1 without the side effects linked to mTORC2 (hyperglycaemia, immunosuppression)?
  5. The lysosome as the weak link: stimulating autophagy is useless if the lysosome is saturated; is TFEB a better target?

7. References

  1. López-Otín C, et al. Hallmarks of aging: an expanding universe. Cell 2023. doi:10.1016/j.cell.2022.11.001
  2. Aman Y, et al. Autophagy in healthy aging and disease. Nat Aging 2021. doi:10.1038/s43587-021-00098-4
  3. Rubinsztein DC, Mariño G, Kroemer G. Autophagy and aging. Cell 2011. doi:10.1016/j.cell.2011.07.030
  4. Hansen M, Rubinsztein DC, Walker DW. Autophagy as a promoter of longevity: insights from model organisms. Nat Rev Mol Cell Biol 2018. doi:10.1038/s41580-018-0033-y
  5. Madeo F, Zimmermann A, Maiuri MC, Kroemer G. Essential role for autophagy in life span extension. J Clin Invest 2015. doi:10.1172/JCI73946
  6. Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell 2019. doi:10.1016/j.cell.2018.09.048
  7. Settembre C, et al. TFEB links autophagy to lysosomal biogenesis. Science 2011. doi:10.1126/science.1204592
  8. Nakamura S, et al. Suppression of autophagic activity by Rubicon is a signature of aging. Nat Commun 2019. doi:10.1038/s41467-019-08729-6
  9. Meléndez A, et al. Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science 2003. doi:10.1126/science.1087782
  10. Hara T, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006. doi:10.1038/nature04724
  11. Komatsu M, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006. doi:10.1038/nature04723
  12. Pyo JO, et al. Overexpression of Atg5 in mice activates autophagy and extends lifespan. Nat Commun 2013. doi:10.1038/ncomms3300
  13. Fernández ÁF, et al. Disruption of the beclin 1–BCL2 autophagy regulatory complex promotes longevity in mice. Nature 2018. doi:10.1038/s41586-018-0162-7
  14. Hampe J, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2006. doi:10.1038/ng1954
  15. Fang EF, et al. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease. Nat Neurosci 2019. doi:10.1038/s41593-018-0332-9
  16. Harrison DE, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009. doi:10.1038/nature08221
  17. Mannick JB, et al. mTOR inhibition improves immune function in the elderly. Sci Transl Med 2014. doi:10.1126/scitranslmed.3009892
  18. Mannick JB, et al. TORC1 inhibition enhances immune function and reduces infections in the elderly. Sci Transl Med 2018. doi:10.1126/scitranslmed.aaq1564
  19. Mannick JB, Lamming DW. Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults. Lancet Healthy Longev 2021. doi:10.1016/S2666-7568(21)00062-3
  20. Moel M, et al. Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results. Aging 2025. doi:10.18632/aging.206235
  21. Eisenberg T, et al. Induction of autophagy by spermidine promotes longevity. Nat Cell Biol 2009. doi:10.1038/ncb1975
  22. Eisenberg T, et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. Nat Med 2016. doi:10.1038/nm.4222
  23. Kiechl S, et al. Higher spermidine intake is linked to lower mortality: a prospective population-based study. Am J Clin Nutr 2018. doi:10.1093/ajcn/nqy102
  24. Schwarz C, et al. Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline: a randomized clinical trial. JAMA Netw Open 2022. doi:10.1001/jamanetworkopen.2022.13875
  25. Ryu D, et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat Med 2016. doi:10.1038/nm.4132
  26. Andreux PA, et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nat Metab 2019. doi:10.1038/s42255-019-0073-4
  27. Liu S, et al. Effect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults: a randomized clinical trial. JAMA Netw Open 2022. doi:10.1001/jamanetworkopen.2021.44279
  28. de Cabo R, Mattson MP. Effects of intermittent fasting on health, aging, and disease. NEJM 2019. doi:10.1056/NEJMra1905136
  29. He C, et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 2012. doi:10.1038/nature10758
  30. Pietrocola F, et al. Spermidine induces autophagy by inhibiting the acetyltransferase EP300. Cell Death Differ 2015. doi:10.1038/cdd.2014.215
  31. García-Prat L, et al. Autophagy maintains stemness by preventing senescence. Nature 2016. doi:10.1038/nature16187
  32. Ho TT, et al. Autophagy maintains the metabolism and function of young and old stem cells. Nature 2017. doi:10.1038/nature21388

DOIs verified via the Crossref API on 2026-10-19.